Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty

Completed · Not applicable

Conditions studied: Wound Heal

In brief

In this prospective pilot study examining the superficial closure during total knee arthroplasty, active subjects will receive the STRATAFIX Spiral Knotless Tissue Control Device for subcuticular closure in addition to DERMABOND PRINEO (Ethicon, Johnson and Johnson, Somerville, New Jersey) system for dermal closure. The control subjects will receive staples (standard-of-care).

Key facts

Study ID
NCT03285542
Run by
The Cleveland Clinic
People needed
60
Starts
2017-09-15
Expected to finish
2019-06-30
Last updated by the study team
2021-05-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.